Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields, this morning said it has joined the 16th cohort of Défi Montréal to accelerate the development and growth of the company. Défi Montréal is the largest innovative business acceleration program in Quebec that helps companies fast-track the development and commercialization of new products. Défi Montréal’s founder, Martin Duchaîne, is a well-known venture capitalist and leader in business financing and development. The company has discovered key individuals to help finance and operate its second distribution facility and has also retained a consulting engineer through its participation in Défi Montréal. “I have known Martin Duchaîne for many years and finally the time has come for us to work together. I am proud to have a mentor with this track record in business development and product positioning. His experience and dedicated coaching means we won’t leave anything to chance,” ETST CEO and Chief Scientific Officer Michel Aubé PhD stated in the news release.
To view the full press release, visit http://ibn.fm/dcDcw
About Earth Science Tech, Inc.
Earth Science Tech has among the highest quality, purity and full-spectrum high-grade hemp CBD (cannabidiol) oil on the market. Made using the superior supercritical CO2 liquid extraction, ETST’s CBD oil is 100% natural and organic. The company’s research, performed alongside the University of Central Oklahoma and DV Biologics laboratory, demonstrates that ETST is the top nutritional and dietary supplement brand for high-grade hemp CBD oil. For more information, visit the company’s website at www.EarthScienceTech.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
